Photo Release -- HALDEY Pharmaceutical Compounding Attracts

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Photo Release -- HALDEY Pharmaceutical Compounding Attracts More Docs as Company Prepares for Its 2nd Open-House Event

NEW YORK, Aug. 16, 2013 (GLOBE NEWSWIRE) -- Doctors invited from throughout the New York metro area weren't disappointed during a free educational gathering earlier this month sponsored by HALDEY Pharmaceutical Compounding.

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=20529

The event, which showcased HALDEY's new state-of-the-art facility in the Bronx, demonstrated some of the latest advances in the field of pharmacy compounding.

Doctors, dentists, nurse practitioners, physician assistants and other medical professionals who couldn't attend the gathering will have another opportunity on Aug. 21, when HALDEY holds its second open-house tour from 5 to 8 p.m., at the company's headquarters, 2510 Westchester Ave., Suite 207. Light refreshments will be served.

During the tour, attendees will journey through the company's newly inaugurated ultra-modern pharmacy with namesake founder Dr. Emil J. Haldey, a doctor of pharmacy and president of the company.

"My staff and I are looking forward to welcoming more doctors to our new home, and providing them with the essential tools needed to incorporate the benefits of pharmaceutical compounding into their treatment options," Dr. Haldey said.

Physicians at the event will have an opportunity to familiarize themselves with the cutting-edge enterprise; get a close-up look at the workings of a state-of-the-art compounding pharmacy; meet with HALDEY pharmacists and technicians; become acquainted with some of the latest advances in custom-tailored medications and applications; learn how to decide which patients could best benefit from compounded medications; master the basics of writing prescriptions for compounded drugs, and discover how easy it can be to assimilate customized pharmaceutical compounding into their practices.

"I am happy working with HALDEY Pharmaceutical Compounding," said Dr. Marina Feldman, director of Interventional Pain Management at General 1 Medical, PC., in Manhattan. "Many of my patients continually benefit from the pharmacy's expertise, and are able to enjoy a better, and pain-free, quality of life."

As event space is limited, visitors are encouraged to reserve their place by calling 855-H-COMPOUND (855-426-6768).

About HALDEY Pharmaceutical Compounding

Unlike many drugstores offering individualized custom-blended medications on a limited or occasional basis, New York City-based HALDEY Pharmaceutical Compounding, as its name implies, specializes in pharmaceutical compounding. Rather than dispensing cookie-cutter solutions, the enterprise focuses solely on tailoring prescriptions to meet the specific needs of each individual patient, including those dealing with unique medical circumstances.

HALDEY Pharmaceutical Compounding's innovative scientific solutions embrace a host of medical and quality-of-life issues, such as pain management; anti-aging and integrative medicine; holistic health; hospice care; dermatology, and health and wellness, to name just a few.

For additional information, HALDEY Pharmaceutical Compounding may be reached at 855-H-COMPOUND (855-426-6768), or via the company's Website: www.hcompound.com .

Media Contact: Barton Horowitz Relevant Public Relations, LLC Headquarters: 718 682 1509 Mobile: 917 715 8761 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Matador Resources CEO's Recent Stock Purchase Signals Confidence

Updated Category News Views 145

Matador Resources CEO Invests in Company Stock In a notable display of confidence in Matador Resources, CEO Joseph Wm Foran has made a significant insider buy, purchasing 2,000 shares of the company’s stock, valued at an impressive $92,500. This transaction was formally reported in a recent filing with the SEC, drawing attention from investors and analysts alike. Market...

Continue Reading
Novonesis Expands Market Reach with Strategic Acquisition

Updated Category News Views 298

Novonesis Acquires dsm-firmenich’s Share of Feed Enzyme Alliance Novonesis has a significant new chapter ahead as it has signed an agreement to take over dsm-firmenich’s portion of the Feed Enzyme Alliance. This agreement is valued at an impressive EUR 1.5 billion, marking a major strategic move for both companies. The dissolution of their collaborative relationship,...

Continue Reading
Star Bulk Carriers Corp. Achieves Impressive $81.3M Profit

Updated Category News Views 74

Star Bulk Carriers Corp. Reports Strong Third Quarter Results Star Bulk Carriers Corp. (NASDAQ: SBLK), a prominent player in the global shipping industry, has recently disclosed its financial performance for the third quarter of 2024. The company announced a striking net profit of $81.3 million during this period, reflecting its robust operational capabilities in the dry...

Continue Reading
Hancock Whitney Achieves $116 Million Net Income Amid Growth

Updated Category News Views 94

Hancock Whitney Corporation's Strong Financial Performance Hancock Whitney Corporation (NASDAQ: HWC) recently announced its financial results for the third quarter of 2024, revealing an impressive net income of $116 million, translating to $1.33 per share. This marks an increase of $1 million from the previous quarter. The bank's substantial performance highlights an...

Continue Reading
Hurricane Helene Approaches: Market Reactions from Generac and Duke Energy

Updated Category News Views 122

Hurricane Helene Approaches Florida: Brace for Impact Florida's gearing up as Hurricane Helene bears down on the state, intensifying from a tropical storm to a hurricane while skirting the Gulf of Mexico. With swirling winds clocking in at around 70 mph, this tempest poses serious risks that have residents on high alert. The Storm is Here: Key Details Currently making its...

Continue Reading